22 May 2013
Keywords: unigene, initiate, phase, iii, trial, osteoporosis, treatment
Article | 09 September 1996
- Unigene has begun a pivotal Phase III trial for Fortical injection
(salmon calcitonin) in the USA, for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 September 1996
21 May 2013
© 2013 thepharmaletter.com